Praxis Precision Medicines Inc. (PRAX) Social Stream
PRAXIS PRECISION MEDICINES INC (PRAX) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering PRAXIS PRECISION MEDICINES INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-12-02 | 5 | $65 | $28 | $46 | $0.877 | 5145.15% |
| 2022-02-13 | 6 | $65 | $28 | $46.5 | $0.877 | 5202.17% |
| 2022-04-27 | 6 | $65 | $27 | $45.5 | $0.877 | 5088.14% |
| 2022-04-28 | 6 | $65 | $27 | $45 | $0.877 | 5031.13% |
| 2022-05-13 | 6 | $65 | $26 | $43.25 | $0.877 | 4831.58% |
| 2022-06-06 | 6 | $65 | $26 | $43.25 | $0.877 | 4831.58% |
| 2022-08-13 | 6 | $18 | $4 | $9 | $0.877 | 926.23% |
| 2022-09-17 | 6 | $18 | $4 | $9.125 | $0.877 | 940.48% |
| 2022-11-11 | 5 | $18 | $3 | $8.875 | $0.877 | 911.97% |
| 2023-01-30 | 6 | $18 | $3 | $8.875 | $0.877 | 911.97% |
| 2023-02-08 | 6 | $18 | $3 | $10.375 | $0.877 | 1083.01% |
| 2023-03-06 | 6 | $18 | $2 | $10.125 | $0.877 | 1054.5% |
| 2023-04-18 | 5 | $18 | $2 | $10.125 | $0.877 | 1054.5% |
| 2023-05-12 | 5 | $18 | $1.5 | $9.375 | $0.877 | 968.99% |
The Trend in the Analyst Price Target
PRAX's average price target has moved down $37.12 over the prior 15 months.
Over the past 49 weeks, PRAX's average upside potential has been 436.1%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-06-06 | 6 | 65 | 26.0 | 43.250 | 1.88 | 2200.53% |
| 2022-09-17 | 6 | 18 | 4.0 | 9.125 | 2.65 | 244.34% |
| 2023-01-30 | 6 | 18 | 3.0 | 8.875 | 4.80 | 84.9% |
| 2023-02-08 | 6 | 18 | 3.0 | 10.250 | 4.34 | 136.18% |
| 2023-05-12 | 5 | 18 | 1.5 | 9.375 | 1.04 | 801.44% |
PRAX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.8 | 3 | 0 | 2 | 0 | 0 | 5 |
The Trend in the Broker Recommendations
Over the past 52 weeks, PRAX's average broker recommendation rating worsened by 0.8.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In the context of all US stocks, PRAXIS PRECISION MEDICINES INC's upside potential (average analyst target price relative to current price) is greater than 1466.06% of them.
- In terms of how PRAXIS PRECISION MEDICINES INC fares relative to all US stocks, note that its variance in analysts' estimates is lower than -1274.35% of that group.
- In the context of stocks in the mid market cap category, PRAXIS PRECISION MEDICINES INC's average analyst price target is higher than 383.96% of them.
- PRAXIS PRECISION MEDICINES INC's number of analysts covering the stock is higher than 455.85% of stocks in the mid market cap category.
In the Pharmaceutical Products industry, RXDX, VERV, and ATAI are the three stocks most similar to PRAXIS PRECISION MEDICINES INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is PRAX a Buy, Hold or Sell? See the POWR Ratings now!